MY141874A - Vaccine formulations comprising an oil-in-water emulsion - Google Patents
Vaccine formulations comprising an oil-in-water emulsionInfo
- Publication number
- MY141874A MY141874A MYPI20060392A MY141874A MY 141874 A MY141874 A MY 141874A MY PI20060392 A MYPI20060392 A MY PI20060392A MY 141874 A MY141874 A MY 141874A
- Authority
- MY
- Malaysia
- Prior art keywords
- immunogen
- emulsion
- oil
- inactivated
- present
- Prior art date
Links
- 239000007764 o/w emulsion Substances 0.000 title abstract 3
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
- 230000002163 immunogen Effects 0.000 abstract 4
- 241001673669 Porcine circovirus 2 Species 0.000 abstract 2
- 244000052769 pathogen Species 0.000 abstract 2
- 230000001717 pathogenic effect Effects 0.000 abstract 2
- 239000004094 surface-active agent Substances 0.000 abstract 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 abstract 1
- -1 FATTY ACID DIESTERS Chemical class 0.000 abstract 1
- 241000204045 Mycoplasma hyopneumoniae Species 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 230000002238 attenuated effect Effects 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 1
- 239000000839 emulsion Substances 0.000 abstract 1
- 239000013604 expression vector Substances 0.000 abstract 1
- 239000000194 fatty acid Substances 0.000 abstract 1
- 229930195729 fatty acid Natural products 0.000 abstract 1
- 239000002480 mineral oil Substances 0.000 abstract 1
- 235000010446 mineral oil Nutrition 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000013612 plasmid Substances 0.000 abstract 1
- 238000003259 recombinant expression Methods 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Abstract
THE PRESENT INVENTION PROVIDES FOR A NOVEL OIL-IN-WATER (O/W) EMULSION, WITH INCREASED STABILITY IN THE PRESENCE OF BACTERIAL OR VIRAL SUSPENSIONS, ESPECIALLY THOSE CONCENTRATED AND NON-PURIFIED OR WEAKLY PURIFIED. THE EMULSION OF THE PRESENT INVENTION CAN ACT AS VEHICLE FOR THE DELIVERY OF A PHARMACEUTICAL COMPOSITION COMPRISING AT LEAST ONE IMMUNOGEN AND, IN PARTICULAR, AN IMMUNOGEN SELECTED FORM THE GROUP COMPRISING AN INACTIVATED PATHOGEN, AN ATTENUATED PATHOGEN, A SUBUNIT, A RECOMBINANT EXPRESSION VECTOR, AND A PLASMID OR COMBINATIONS THEREOF. IN ONE EMBODIMENT, THE PRESENT INVENTION PROVIDES FOR AN INJECTABLE OIL-IN-WATER (O/W) EMULSION COMPRISING: (1) AN AQUEOUS SOLUTION CONTAINING AN IMMUNOGEN, SAID IMMUNOGEN SELECTED FROM THE GROUP COMPRISING AN INACTIVATED MYCOPLASMA HYOPNEUMONIAE BACTERIUM, AN INACTIVATED D PORCINE CIRCOVIRUS TYPE 2 (PCV-2) VIRUS OR COMBINATIONS THEREOF; (2) A MINERAL OIL; (3) A NON-IONIC LIPOPHILIC SURFACTANT; AND (4) A NON-IONIC HYDROPHILIC SURFACTANT HAVING A LOW HLB VALUE WHICH COMPRISES ETHOXYLATED FATTY ACID DIESTERS OF SORBITAN (GENERALLY HAVING HLB VALUE BETWEEN 11 AND 13).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MYPI20060392 MY141874A (en) | 2006-01-27 | 2006-01-27 | Vaccine formulations comprising an oil-in-water emulsion |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MYPI20060392 MY141874A (en) | 2006-01-27 | 2006-01-27 | Vaccine formulations comprising an oil-in-water emulsion |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY141874A true MY141874A (en) | 2010-07-16 |
Family
ID=44256677
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI20060392 MY141874A (en) | 2006-01-27 | 2006-01-27 | Vaccine formulations comprising an oil-in-water emulsion |
Country Status (1)
| Country | Link |
|---|---|
| MY (1) | MY141874A (en) |
-
2006
- 2006-01-27 MY MYPI20060392 patent/MY141874A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI1651265T1 (en) | Vaccine formulations comprising an oil-in-water emulsion | |
| SG179037A1 (en) | New vaccine formulations comprising saponin-containing adjuvants | |
| UA94404C2 (en) | Novel vaccine formulations | |
| CO6251369A2 (en) | WATER OIL EMULSION INFLUENZA VACCINE | |
| BR0204470A (en) | Use of flaviviruses for the expression of protein epitopes and for the development of a novel live attenuated vaccine virus for immunization against flaviviruses and other infectious agents. | |
| CL2010000657A1 (en) | Effective immunogenic composition against an infection by pcv2 comprising at least 0.2 ug of recombinant orf2 protein from pcv2 (divisional application 3475-05). | |
| AR075437A1 (en) | IMMUNOGENIC COMPOSITION THAT INCLUDES AT LEAST ONE ANTIGEN OF THE VIRUS OF THE INACTIVATED DENGUE AND AN ADJUVANT WITHOUT ALUMINUM, METHOD FOR PRODUCING THIS VACCINE AND ITS USE TO PREPARE A MEDICINAL PRODUCT | |
| PL395509A1 (en) | Immunogenic polypeptide product, a viral vaccine against viral infection or postweaning multisystemic wasting syndrome induced by PCV2 and their applications | |
| BR112021020957A2 (en) | Variant adeno-associated virus (aav) capsids for intravitreal delivery | |
| JP2009504805A (en) | Nanoemulsion composition having anti-inflammatory activity | |
| AR059688A1 (en) | USE OF ALPHA - TOXIN TO TREAT AND PREVENT INFECTIONS BY STAPHYLOCOCCUS | |
| WO2007117303A3 (en) | Combination vaccine comprising an attenuated bovine viral diarrhea virus | |
| JP6907227B2 (en) | Combined vaccine against PCV2 virus and Mycoplasma hyopinium infection | |
| MA32030B1 (en) | Malaria vaccines | |
| CO6300827A2 (en) | AGRICULTURAL COMPOSITIONS THAT INCLUDE A WATER OIL EMULSION COMPOSITION THAT HAS AN OIL PHASE AND A WATER PHASE | |
| ZA202301438B (en) | Aa v5-based vaccine against sars-cov-2 | |
| PY21111761A (en) | AAV5-BASED VACCINE FOR THE INDUCTION OF SPECIFIC IMMUNITY AGAINST SARS-COV-2 AND/OR THE PREVENTION OF SARS-COV-RELATED CORONAVIRUS INFECTION | |
| CR20170280A (en) | VACCINE COMPOSITIONS FOR DENGUE VIRUSES AND METHODS OF THE SAME USE | |
| AR052162A1 (en) | STABILIZED INJECTABLE PHARMACEUTICAL COMPOSITIONS WITH POSACONAZOL PARTICULATES | |
| MX2024000330A (en) | Universal vaccine for influenza virus based on tetrameric m2 protein incorporated into nanodiscs. | |
| BR0112486A (en) | Polyprotein, nucleic acid molecule, plasmid, recombinant vaccine or attenuated vaccine, pharmaceutical composition, and method for immunizing an individual against HIV. | |
| CL2025003846A1 (en) | Vaccine formulation comprising a surfactant that does not comprise an ester linkage | |
| UY29523A1 (en) | FORMULATIONS OF NEW VACCINES |